Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes

Proteomics

Volumn 11, Issue 2, 2011, Pages 283-297

  Hong, Hye Min ^a   Song, Eun Joo ^a   Oh, Eulsik ^a   Kabir, Mohammad Humayun ^a,b   Lee, Cheolju ^a,b   Yoo, Young Sook ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

2 DE; Cardiac hypertrophy; Cell biology; Endothelin 1; HL 1 cardiomyocytes; Isoproterenol

Indexed keywords

ENDOTHELIN 1; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL LINE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CARDIOMEGALY; CARDIOTONIC AGENTS; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HUMANS; ISOPROTERENOL; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; PROTEINS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 78650798735     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000018     Document Type: Article

References (38)

1. Cheng, H., Force, T., Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics. Circ. Res. 2010, 106, 21-34.
2. Lorenz, K., Schmitt, J. P., Vidal, M., Lohse, M. J., Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int. J. Biochem. Cell. Biol. 2009, 41, 2351-2355.
3. Molkentin, J. D., Dorn, G. W., 2nd, Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 2001, 63, 391-426.
4. Glenn, D. J., Rahmutula, D., Nishimoto, M., Liang, F., Gardner, D. G., Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc. Res. 2009, 84, 209-217.
5. Hannan, R. D., Jenkins, A., Jenkins, A. K., Brandenburger, Y., Cardiac hypertrophy: a matter of translation. Clin. Exp. Pharmacol. Physiol. 2003, 30, 517-527.
6. Usui, S., Yeh, I., Tian, B., Sadoshima, J., Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research. J. Mol. Cell. Cardiol. 2006, 41, 219-222.
7. Sugden, P. H., Clerk, A., Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 1998, 76, 725-746.
8. Frey, N., Olson, E. N., Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 2003, 65, 45-79.
9. Woodcock, E. A., Du, X. J., Reichelt, M. E., Graham, R. M., Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc. Res. 2008, 77, 452-462.
10. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol. Cell 2009, 33, 472-482.
11. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 2000, 275, 15239-15245.
12. Heineke, J., Molkentin, J. D., Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 2006, 7, 589-600.
13. Ueyama, T., Kawashima, S., Sakoda, T., Rikitake, Y. et al., Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J. Mol. Cell. Cardiol. 2000, 32, 947-960.
14. Agnetti, G., Bezstarosti, K., Dekkers, D. H., Verhoeven, A. J. et al., Proteomic profiling of endothelin-1-stimulated hypertrophic cardiomyocytes reveals the increase of four different desmin species and α-B-crystallin. Biochim. Biophys. Acta 2008, 1784, 1068-1076.
15. White, S. M., Constantin, P. E., Claycomb, W. C., Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H823-H829.
16. Claycomb, W. C., Lanson, N. A., Jr., Stallworth, B. S., Egeland, D. B. et al., HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA 1998, 95, 2979-2984.
17. Kim, H. J., Song, E. J., Lee, K. J., Proteomic analysis of protein phosphorylations in heat shock response and thermotolerance. J. Biol. Chem. 2002, 277, 23193-23207.
18. Kim, Y. M., Song, E. J., Seo, J., Kim, H. J., Lee, K. J., Proteomic analysis of tyrosine phosphorylations in vascular endothelial growth factor- and reactive oxygen species-mediated signaling pathway. J. Proteome Res. 2007, 6, 593-601.
19. Levänen, B., Wheelock, A. M., Troubleshooting image analysis in 2DE. Methods Mol. Biol. 2009, 519, 113-129.
20. Kang, U. B., Ahn, Y., Lee, J. W., Kim, Y. H. et al., Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer 2010, 10, 114
21. Eng, J. K., McCormack, A. L., Yates, J. R., An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989.
22. Haq, S., Choukroun, G., Kang, Z. B., Ranu, H. et al., Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 2000, 151, 117-130.
23. Jayaraman, T., Brillantes, A. M., Timerman, A. P., Fleischer, S. et al., FK506 binding protein associated with the calcium release channel (Ryanodine receptor). J. Biol. Chem. 1992, 267, 9274-9477.
24. Liao, W., Wang, S., Han, C., Zhang, Y., 14-3-3 Protein regulate glycogen synthase 3β phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J. 2005, 272, 1845-1854.
25. Zhang, S., Ren, J., Zhang, C. E., Treskov, I. et al., Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ. Res. 2003, 93, 1026-1028.
26. Jamshidi, Y., Zourlidou, A., Carroll, C. J., Sinclair, J., Latchman, D. S., Signal-transduction pathways involved in the hypertrophic effect of hsp56 in neonatal cardiomyocytes. J. Mol. Cell. Cardiol. 2004, 36, 381-392.
27. Railson, J. E., Lawrence, K., Buddle, J. C., Pennica, D., Latchman, D. S., Heat shock protein-56 is induced by cardiotrophin-1 and mediates its hypertrophic effect. J. Mol. Cell. Cardiol. 2001, 33, 1209-1221.
28. Casey, T. M., Arthur, P. G., Bogoyevitch, M. A., Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro. Mol. Cell. Proteomics 2005, 4, 651-661.
29. Kudoh, A., Matsuki, A., Halothane and sevoflurane decrease norepinephrine-stimulated glucose transport in neonatal cardiomyocyte. Anesth. Analg. 2000, 91, 1151-1159.
30. Shizukuda, Y., Buttrick, P. M., Isoprotrenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 2002, 105, E9.
31. Barry, S. P., Davidson, S. M., Townsend, P. A., Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell. Biol. 2008, 40, 2023-2039.
32. Bueno, O. F., Molkentin, J. D., Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 2002, 91, 776-781.
33. Bueno, O. F., De Windt, L. J., Tymitz, K. M., Witt, S. A. et al., The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 2000, 19, 6341-6350.
34. Sanna, B., Bueno, O. F., Dai, Y. S., Wilkins, B. J., Molkentin, J. D., Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol. Cell. Biol. 2005, 25, 865-878.
35. Condorelli, G., Drusco, A., Stassi, G., Bellacosa, A. et al., Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. USA 2002, 99, 12333-12338.
36. Kim, Y. K., Kim, S. J., Yatani, A., Huang, Y. et al., Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J. Biol. Chem. 2003, 278, 47622-47628.
37. Caraci, F., Gili, E., Calafiore, M., Failla, M. et al., TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol. Res. 2008, 57, 274-282.
38. Latronico, M. V., Costinean, S., Lavitrano, M. L., Peschle, C., Condorelli, G., Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann. N. Y. Acad. Sci. 2004, 1015, 250-260.